Drug Shortage Report for OGIVRI

Last updated on 2020-07-31 History
Report ID 120774
Drug Identification Number 02474433
Brand name OGIVRI
Common or Proper name TRASTUZUMAB
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TRASTUZUMAB WATER
Strength(s) 440MG 20ML
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1VL TRASTUZUMAB 1VL BWFI
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-07-17
Estimated end date 2020-08-04
Actual end date 2020-07-30
Shortage status Resolved
Updated date 2020-07-31
Company comments Limited product supply is available on allocation
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-07-31 English Compare
v5 2020-07-30 French Compare
v4 2020-07-30 English Compare
v3 2020-07-30 English Compare
v2 2020-07-22 French Compare
v1 2020-07-22 English Compare